Tumor drug exposure is positively correlated with an improved outcome, in patients with advanced solid tumors, upon treatment with a high dose intermittent sunitinib regimen

S. Gerritse, R. ter Heine, M. Labots, E. van den Hombergh, H. Dekker, D. Lehutová, M. Rudek, N. van Erp, H. Verheul

Research output: Contribution to journalArticleAcademicpeer-review

Cite this